The genetic overlap of attention deficit hyperactivity disorder and autistic spectrum disorder by Stam, A.J. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
© 2009 Stam et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
The Application of Clinical Genetics 2009:2 7–13 7
R E V I E W
The genetic overlap of attention defi cit 






University Medical Center Utrecht 
(UMC Utrecht), Utrecht, 
The Netherlands
Correspondence:  Wouter G Staal
A 01.469, PO Box 85500, 3508 GA 
Utrecht, The Netherlands
Tel +31 887 58 141
Fax +31 887 55 444
Email w.staal@umcutrecht.nl
Abstract: Autistic spectrum disorders (ASD) and attention deﬁ cit hyperactivity disorder 
(ADHD) are classiﬁ ed as distinct disorders within the DSM-IV-TR (1994). The manual excludes 
simultaneous use of both diagnoses in case of overlap on a symptomatic level. However this 
does not always represent clinical observations and ﬁ ndings of previous studies. This review 
explores the genetic basis of the phenomenological overlap between ADHD and ASD. Based 
on an extensive review of twin-, linkage-, association studies, and reported structural genomic 
abnormalities associated with these disorders, we have identiﬁ ed seventeen regions on the human 
genome that can be related to both disorders. These regions of shared genetic association are: 
2q35, 3p14, 4p16.1, 4p16.3, 5p15.31, 5p15.33, 7p12.3, 7p22, 7q21, 8q24.3, 14q12, 15q11–12, 
16p13, 17q11, 18q21–23, 22q11.2, Xp22.3. The presented data are of interest for future genetic 
studies and appear to suggest the existence of a phenotype partition that may differ from the 
current classiﬁ cation of psychiatric disorders.
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Introduction
Attention deﬁ cit hyperactivity disorder (ADHD) is a common childhood psychiatric 
disorder, with a variety of symptoms and a worldwide prevalence between 8%–12% 
or around 2% when signiﬁ cant impairment is included within the diagnostic criteria.1,2 
ADHD is one of the best-validated childhood diagnoses.3 Autistic spectrum disorders 
(ASD) are pervasive developmental disorders that originate in early childhood and 
include autistic disorder (AD), Rett syndrome, Asperger syndrome, and pervasive 
development disorders – not otherwise speciﬁ ed (PDD-NOS).4 The reported prevalence 
of ASD has increased over the past 20 years and current estimated prevalence ﬁ gures 
range from 27.5 to 107.6 per 10,000.5,6
The risk to develop ADHD and ASD is largely determined by genetic factors, as 
has been shown in several family and twin studies. On average, the genetic risk for 
ADHD is estimated to be 76% as can be deducted from twin studies from Europe, the 
United States, and Australia.7–13
For ASD, twin studies in autism have provided concordance rates between 
36%–96% for monozygotic twins and 0%–30% for dizygotic twin pairs of the same 
sex.14 Based on these ﬁ ndings, it is estimated that the genetic risk for autism is over 
90%. It has also been suggested that twinning itself might be part of the etiology of 
ASD, but this has been contested.15
ADHD and ASD are traditionally considered distinct and the diagnosis of ADHD 
still belongs to the exclusionary criteria for ASD.16 However, cumulative evidence from 
behavioral studies, neurocognitive studies and genetic studies suggests an etiological 
overlap between ADHD and ASD.16–26 Both are early-onset psychiatric disorders 
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placed within the realm of child- and adolescent psychiatry.4 
A considerable amount of ADHD patients show problems 
in communication and social interaction as observed in 
ASD.23–25 In addition, autistic children often show high levels 
of impulsivity, inattention, and hyperactivity.16,20,21 It has been 
suggested by family and twin studies that these overlapping 
traits can be explained by common genetic inﬂ uences.22–26
This review focuses on the overlap in genetic association 
of ADHD and ASD, in order to provide a stronger basis for 
understanding the shared biological processes which affect 
cognitive domains which may underlie both disorders. The 
aim of this study is to provide a clear overview of all genomic 
regions associated to ADHD or ASD, thereby identifying 
regions of shared genetic overlap between these disorders.
Methods
This review is based upon a literature survey within the 
PubMed database and Google Scholar search engine. First, 
the latest reviews about the genetics of autism and ADHD 
were selected for a broad orientation. Next, a systematic 
evaluation by using combinations of keywords including 
ADHD, Autis*, gene*, overlap, molecul*, etc. within these 
databases was performed. Studies were selected based on 
several criteria including diagnostic methods and a ﬁ xed 
statistical threshold with regard to linkage and association 
studies. With regard to ADHD, studies on the combined 
subtype, as well as all studies including patients with the 
inattentive or with the hyperactive subtype were included 
in this review. For ASD the studies which involved subjects 
diagnosed with autistic disorder, Asperger’s disorder and 
PDD-NOS according to DSM-IV (TR) criteria were included. 
For linkage studies to be included in this review, a logarithm 
of odd (LOD) score of 2.2 (suggestive linkage) or higher was 
required.27 In order to minimize the risk of overinterpretation, 
linkage regions were conservatively deﬁ ned as extending 
10 kb at either side of the reported marker. Only the occur-
rence of other independent ﬁ ndings within this region was 
considered as possible overlap.
The signiﬁ cance threshold (corrected for multiple testing), 
reported in association studies was considered signiﬁ cant when 
P  0.05, and reported P-values between 0.05 and 0.10 were 
considered as suggestive. Only regions indicated by signiﬁ -
cant results were included in this review, however, a genomic 
region was also included when supported by suggestive 
results of two or more studies. Studies on cytogenetic abnor-
malities and case reports involving patients with cytogenetic 
abnormalities were only included if a validated checklist 
and/or a diagnosis according to DSM or ICD classiﬁ cation 
was described, as well as an interpretable annotation of the 
involved genomic region.
All overlapping linkage and cytogenetic regions meeting 
these criteria were considered as loci putatively containing risk 
genes for a common etiology between ADHD and ASD.
Results
The loci and genes found in both ASD and ADHD by the 
literature survey are represented below. Figure 1 provides 
a complete and schematic overview of all included studies. 
Table 1 describes the 17 regions of overlap including the 
boundaries and involved studies.
Discussion
This review provides an overview of a joint genetic basis 
for ASD and ADHD through association-, linkage-, and 
cytogenetic studies. Seventeen regions on the human 
genome can be related to both disorders including: 2q35, 
3p14, 4p16.1, 4p16.3, 5p15.31, 5p15.33, 7p12.3, 7p22, 
7q21, 8q24.3, 14q12, 15q11–12, 16p13, 17q11, 18q21–23, 
22q11.2, Xp22.3. These regions reﬂ ect about 36% of the loci 
involved in ADHD, whereas they reﬂ ect about 14% of the 
regions related to ASD.
These ﬁ ndings suggest that at least some shared genetic 
risk factors exist between ADHD and ASD, which may have 
implications for our concepts of these disorders.
However, for an adequate interpretation of these ﬁ ndings 
it is important to bear in mind that several limitations exist 
in our evaluation of the literature.
First, it is possible that some studies with relevant 
information were missed during the literature search. For 
example, studies that do not find associations with the 
regions described in this review are possibly less likely to 
be submitted for publication, leading to a publication-based 
biased overview of associated regions.
Second, pragmatic decisions have been made regard-
ing the representation of linkage studies. Unfortunately, 
no consensus exists about the precise distance around the 
linkage peak that should be considered important. More-
over, generally weak signiﬁ cance scores are found for both 
disorders. This can be explained by the genetic complexity 
of the disorders and the small sample sizes of certain studies. 
In order to minimize the risk of type 1 errors, we have opted 
for a fairly conservative deﬁ nition of linkage (10 kb at either 
side of the reported marker) for the current analysis.
Third, it is quite possible that although loci for ASD and 
ADHD overlap, different genes within these overlap regions 
are related to each disorder.
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Fourth, we have focused on positive association ﬁ ndings. 
This elicits the risk of type 1 errors, since the majority of 
reported loci show contradictory ﬁ ndings about putative 
association. This can be partly explained by different methods 
and sample sizes, as well as variety in ethnicity of the studied 
samples. We propose that the association with both ADHD 
and ASD could be considered as additional evidence in 
support of the involvement of a locus.
Despite these limitations, the results of our analysis suggest 
that shared genetic etiologies may exist for ADHD and ASD, 
which may have implications for our clinical concepts of the 
disorders and the existing diagnostic procedures. The results 
Figure 1 The genetic overlap of ADHD and ASD.
Notes:  This fi gure shows 24 human chromosomes. On the left side of each chromosome the results of genetic studies on ADHD are provided. On the right side of each chro-
mosome the genetic fi ndings on ASD are given. Linkage studies are represented by black dotted horizontal lines.  Association studies are indicated by blue dotted horizontal lines. 
Cytogenetic studies are vertical lines in the colors green, orange and red.  A green line represents a region described by one study.  An orange line represents a region described 
by two, three our four studies.   A red line represents a region described by fi ve or more studies. Regions containing overlap in genetic fi ndings associated to both ASD and ADHD 
are accentuated by a red box surrounding the region of interest.  All data included in this fi gure are exactly positioned. Further details can be found in Table 1.
Abbreviations:  ADHD, attention defi cit hyperactivity disorder;  ASD, autistic spectrum disorders.
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of this paper provide a biological argument for applying a less 
stringent nosology. In fact, the existing exclusionary criteria 
for both disorders within the DSM-IV should be reconsidered. 
Moreover, this paper provides the biological argument to allow 
a more pragmatic view regarding treatment of overlapping 
symptoms, which could otherwise be missed.
Several methodological advantages of this study 
strengthen this interpretation of data.
First of all, the study provides a complete overview of 
associated genomic regions of both disorders. This is relevant, 
because a substantial genetic inﬂ uence for both disorders was 
described, with a higher genetic risk for ASD than for ADHD. 
Our search for shared genetic association between ASD and 
ADHD is motivated by the clinical overlap between both 
disorders and the ﬁ ndings from twin and family studies.
Second, this review provides the basis for a bottom-up 
approach in research on the overlap of ADHD and ASD. 
Seventeen putative loci relevant for a molecular explanation of 
the overlap between ADHD and autism have been described. 
These include: 2q35, 3p14, 4p16.1, 4p16.3, 5p15.31, 5p15.33, 
7p12.3, 7p22, 7q21, 8q24.3, 14q12, 15q11–12, 16p13, 17q11, 
18q21–23, 22q11.2, Xp22.3. Although the interpretation of 
the results may not be straightforward and further research is 
clearly necessary, our ﬁ ndings do appear to provide robust, 
albeit indirect evidence for at least some shared genetic overlap 
between ASD and ADHD. This notion is consistent with the 
ﬁ ndings of a recent twin study.22 The implicated regions 
of the current study may be of help when interpreting data 
from ongoing genome-wide association studies for ADHD 
and autism. Furthermore, these ﬁ ndings are in line with the 
emerging hypothesis that nosologically distinct psychiatric 
phenotypes, such as ADHD and ASD, or schizophrenia and 
bipolar disorder, may have shared biological etiologies.119
In conclusion, ﬁ ndings of our analysis are in support of 
shared genetic etiologies for ASD and ADHD. A pragmatic 
consequence of this ﬁ nding may be that it provides some 
justiﬁ cation for a combined analysis of genetic association 
for ASD and ADHD. On a more conceptual level, our 
results suggest that the biology of ASD and ADHD does 
not seem to follow the boundaries laid out by our nosologic 
classiﬁ cation system.
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